DGAP-Adhoc: M1 Kliniken AG: Corona pandemic: M1 group suspends all treatments from 21.03.2020 until Monday 13.04.2020. Cooperation offers for local health authorities planned.
|
DGAP-Ad-hoc: M1 Kliniken AG / Key word(s): Change in Forecast/Legal Matter
M1 Kliniken AG: Corona pandemic: M1 group suspends all treatments from 21.03.2020 until Monday 13.04.2020. Cooperation offers for local health authorities planned.
17-March-2020 / 16:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Corona pandemic: M1 group suspends all treatments from 21.03.2020 until Monday 13.04.2020. Cooperation offers for local health authorities planned.
- The M1 Group will close all clinic and practice locations for beauty treatments from 21.03.2020.
- Impact of corona pandemic on sales limited so far.
- Offers to health authorities to use the practice infrastructure as a corona or Covid19 test centres are planned.
Berlin, 17.03.2020 - M1 Kliniken AG today decided to close all clinic and practice locations for beauty treatments with effect from 21 March 2020. An assessment of the further development and duration of the closure of the facilities will be made in the week before Easter (6-9 April 2020).
To date, M1 sales have been only marginally affected by the corona pandemic. In addition, the company assumes that the old sales volume can be reached very quickly after the re-opening of the clinics.
It is planned to make the infrastructure available to the local health authorities as test sites during the period of closure of the practice and clinic operations.
About M1 Kliniken AG
M1 Kliniken AG is the leading provider of beauty medicine health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality. Under the brands M1 Med Beauty, M1 Laser and M1 Dental, beauty medical treatments are currently offered at more than 25 locations. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with its international expansion and is currently active in Austria, the Netherlands, UK and Australia. The Group is now also growing in other European countries and markets high-quality products to private customers, doctors, pharmacies and wholesalers under the M1 Select and M1 Aesthetics brands. www.m1-kliniken.de
Contact:
Patrick Brenske, Management Board
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Phone: +49 (0)30 347 47 44 14
E-Mail: [email protected]
17-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
M1 Kliniken AG |
|
Grünauer Straße 5 |
|
12557 Berlin |
|
Germany |
| Phone: |
+49 (0)30 347 47 44 14 |
| Fax: |
+49 (0)30 347 47 44 17 |
| E-mail: |
[email protected] |
| Internet: |
https://www.m1-kliniken.de |
| ISIN: |
DE000A0STSQ8 |
| WKN: |
A0STSQ |
| Listed: |
Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange |
| EQS News ID: |
999295 |
| |
| End of Announcement |
DGAP News Service |
999295 17-March-2020 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
47,19 |
65,21 |
77,27 |
159,59 |
314,61 |
285,29 |
302,00 |
| EBITDA1,2 |
6,18 |
7,17 |
11,33 |
8,89 |
17,82 |
15,41 |
19,85 |
| EBITDA-Marge3 |
13,10 |
11,00 |
14,66 |
5,57 |
5,66 |
5,40 |
|
| EBIT1,4 |
5,71 |
6,46 |
7,93 |
4,41 |
12,13 |
9,35 |
14,40 |
| EBIT-Marge5 |
12,10 |
9,91 |
10,26 |
2,76 |
3,86 |
3,28 |
4,77 |
| Jahresüberschuss1 |
5,78 |
6,61 |
9,73 |
7,43 |
10,88 |
7,07 |
9,50 |
| Netto-Marge6 |
12,25 |
10,14 |
12,59 |
4,66 |
3,46 |
2,48 |
3,15 |
| Cashflow1,7 |
2,09 |
2,86 |
-5,37 |
9,54 |
15,68 |
20,77 |
0,00 |
| Ergebnis je Aktie8 |
0,38 |
0,39 |
0,56 |
0,37 |
0,45 |
0,22 |
0,39 |
| Dividende8 |
0,30 |
0,30 |
0,00 |
0,00 |
0,00 |
0,00 |
0,30 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: wetreu NTRG
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| M1 Kliniken |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A0STSQ |
13,550 |
Kaufen |
266,17 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 19,64 |
28,14 |
0,71 |
35,75 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,72 |
12,82 |
0,93 |
16,55 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
17.07.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 06.06.2024 |
03.09.2024 |
16.11.2023 |
23.05.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 5,84% |
33,60% |
20,98% |
71,52% |
|
|
M1 Kliniken AG DE000A0STSQ8